Prot #APD334-003: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Study to Investigate the Safety and Efficacy of APD334 in Patients with Moderately to Severely Active Ulcerative Colitis

    Project: Research project

    Project Details

    StatusFinished
    Effective start/end date4/21/164/21/19

    Funding

    • Covance Inc. (Prot #APD334-003)
    • Arena Pharmaceuticals, Inc. (Prot #APD334-003)